EPISODE · Jun 22, 2023 · 28 MIN
Widespread use of Ozempic for weight loss could change how we view fatness
from Don’t Call Me Resilient · host Vinita Srivastava
It seems like everyone you talk to has considered taking Ozempic, the drug originally created as a diabetes treatment, but now being used as a weight-loss method.Ever since it arrived in Canada, it’s been in incredibly high demand.While Ozempic may be just the next in a long line of get-thin-quick fads, the drug’s shortages have disproportionate impacts on racialized communities. So do the weight-loss goals that undergird those shortages.
Embed this episode
What this episode covers
In this episode of Don't Call Me Resilient, we are joined by fat and disability studies professor Fady Shanouda, who examines anti-fat bias in medicine. As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
NOW PLAYING
Widespread use of Ozempic for weight loss could change how we view fatness
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.